Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04170283
Title Long-term Extension Study of Zanubrutinib (BGB-3111) in Patients With B-cell Malignancies
Recruitment Enrolling by invitation
Gender both
Phase Phase III
Variant Requirements No
Sponsors BeiGene
Indications

B-cell adult acute lymphocytic leukemia

B-cell lymphoma

Therapies

Zanubrutinib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU


No variant requirements are available.